GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.

Alzheimer's Research, #FDA, Brain Health, BioMarkers Corey Hubbafd Alzheimer's Research, #FDA, Brain Health, BioMarkers Corey Hubbafd

Brain2Qwerty's Magnetoencephalography (MEG) System: A Paradigm Shift in Neuroscience Research

Neuroscience research has long sought to unravel the intricate workings of the human brain, aiming to understand the neural basis of cognition, behavior, and consciousness. Among the various neuroimaging techniques available, magnetoencephalography (MEG) stands out for its exceptional temporal resolution, offering a millisecond-by-millisecond glimpse into brain activity.

Read More
DNA, AI in Healthcare, Clinical Trials, FDA Corey Hubbafd DNA, AI in Healthcare, Clinical Trials, FDA Corey Hubbafd

The Sociogenomics Revolution

For generations, humanity has grappled with one of life's most profound questions: are we products of our genes or our upbringing? This "nature versus nurture" debate has fueled countless discussions, academic papers, and even political stances. On one side stand the "blank-slaters," who believe our environment is the primary sculptor of who we become. On the other, the "hereditarians" argue that our destiny is largely etched in our genetic code.

Read More
FDA Compliance, AI Ethics, HealthyAging, Biotech & Drug Discovery Corey Hubbafd FDA Compliance, AI Ethics, HealthyAging, Biotech & Drug Discovery Corey Hubbafd

Dementia Risk After 90: New Study Shows Why We're Never In the Clear

It is a common and comforting assumption: if you or your loved ones can make it to 90 years old with a sharp mind, you have somehow beaten the odds. We tend to think that after a certain milestone, the risk of cognitive decline plateaus, and we can finally breathe a sigh of relief.

Read More
Alzheimer's Research, FDA, NIA, Biotech & Drug Discovery Corey Hubbafd Alzheimer's Research, FDA, NIA, Biotech & Drug Discovery Corey Hubbafd

A Legacy of Mistrust: Understanding and Addressing Vaccine Hesitancy Among People of Color

The recent COVID-19 pandemic has laid bare a stark reality: people of color (POC) are disproportionately hesitant to engage with medical and governmental institutions, particularly regarding vaccinations. This hesitancy, often labeled as "vaccine hesitancy," is not simply a matter of ignorance or fear. It is rooted in a deeply ingrained distrust that stems from a long history of systemic racism and medical discrimination.

Read More